Results of conservative surgery and radiation for mammographically detected ductal carcinoma in situ (DCIS)

https://doi.org/10.1016/S0360-3016(97)00153-3Get rights and content

Abstract

Purpose: The role of conservative surgery and radiation for mammographically detecged ductal carcinma in situ (DCIS) is controversial. In particular, there is little date for outcome with radiation in a group of patients comparable to those treated with local excision and surveillance (mammographic calcifications ≤2.5cm, negative resection margins, negative postbiopsy mammogram). This study reports outcome of conservative surgery and radiation for mammographically detected DCIS with an emphasis on results in patients considered candidates for excision alone.

Methods and Materials: From 1983 to 1992, 110 women with mammographically detected DCIS (77% calcifications ± mass) and no prior history of breast cancer underwent needle localization and biopsy with (55%) or without a reexicision and radiation. Final margins of resection were negative in 62%, positive 7%, close 11%, and unknown 20%. The median patient age was 56 years. The most common histologic subtype was comedo (54%), followed by cribriform (22%). The median pathologic tumor size was 8 mm (range 2 mm to 5 cm). Forty-seven percent of patients with calcifications only had a negative postbiopsy mammogram prior to radiation. Radiation consisted of treatment to the entire breast (median 50.00 Gy) and a boost to the primary site (97%) for a median total dose of 60.40 Gy.

Results: With a median follow-up of 5.3 years, three patients developed a recurrence in the treated breast. The median interval to recurrence was 8.8 years and all were invasive cancers. Two (67%) occurred outside the initial quadrant. The 5- and 10-year actuarial rates of recurrence were 1 and 15%. Cause-specific survival was 100% at 5 and 10 years. Contralateral breast cancer developed in two patients. There were too few failures for statistical significance to be achieved with any of the following factors: patient age, family history, race, mammographic findings, location primary, pathologic size, histologic subtype, reexcision, or final margin status. However, young age, positive or close margins, and the presence of a mass without calcifications had a trend for an increased risk of recurrence. There were no recurrences in the subset of 16 patients who would be candicates for surveillance by Lagio's criteria.

Conclusion: For selected patients, conservative surgery and radiation for mammographically detected DCIS results in a low risk of recurrence in the treated breast and 100% 5- and 10-year cause-specific survival. Improved mammographic and pathologic evaluation results in better patient selection and reduced the risk of the subsequent appearance of DCIS in the biopsy site. The identification of risk factors for an ipsilateral invasive breast recurrence is evolving.

References (30)

  • E.R. Fisher et al.

    Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)

    Cancer

    (1995)
  • W.J. Gallagher et al.

    Treatment of intraductal carcinoma with limited surgery: Long term follow-up

    J. Clin. Oncol.

    (1989)
  • H. Hiramatsu et al.

    Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ. Possible importance of family history

    Cancer J. Sci. Am.

    (1995)
  • E.L. Kaplan et al.

    Non-parametric estimation from incomplete observation

    J. Am. Stat. Assoc.

    (1958)
  • M.D. Lagios

    Duct carcinoma in situ: Biological implications for clinical practice

    Sem. Oncol.

    (1996)
  • Cited by (87)

    • Vitamin D compounds reduce mammosphere formation and decrease expression of putative stem cell markers in breast cancer

      2015, Journal of Steroid Biochemistry and Molecular Biology
      Citation Excerpt :

      The treatment of DCIS typically consists of surgery, radiation, and when necessary, hormonal therapy. Despite the effective treatment regimen and initial response to therapy, approximately 15% of patients with DCIS will relapse [2]. Additionally, 30–50% of DCIS cases will progress to invasive ductal carcinoma (IDC) if left untreated [3,4].

    • Breast Cancer: Stages I-II

      2015, Clinical Radiation Oncology
    • Characterization of a stem-like subpopulation in basal-like ductal carcinoma in situ (DCIS) lesions

      2014, Journal of Biological Chemistry
      Citation Excerpt :

      Therapeutic management of DCIS involves surgery, radiation, and where appropriate, hormonal therapies (1). Roughly 15% of patients with DCIS show recurrent disease following therapy (2). Identifying which patients are at greatest risk for disease recurrence and progression to invasive disease is a critical issue facing clinicians.

    • Factors associated with residual disease after initial breast-conserving surgery for ductal carcinoma in situ

      2012, Human Pathology
      Citation Excerpt :

      Tumor size remained as a greatly controversial factor [9,13,20,21]. Of potential prognostic factors, margin status has been given the most attention in regard to the success of BCS for DCIS, although its association with recurrence was variable [3-6,9,10,13,22-30]. Although consensus regarding optimal margin width is lacking, a margin threshold of 2 mm has been generally accepted by most North American radiation oncologists when BCS is combined with radiation therapy [2].

    • Breast Cancer: Stages I and II

      2012, Clinical Radiation Oncology: Third Edition
    View all citing articles on Scopus
    View full text